Point72 Middle East FZE’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,900
Closed -$494K 208
2023
Q4
$494K Buy
4,900
+3,400
+227% +$337K 0.01% 826
2023
Q3
$130K Buy
1,500
+500
+50% +$45.2K ﹤0.01% 1097
2023
Q2
$94.6K Buy
+1,000
New +$84.5K ﹤0.01% 1211
2023
Q1
Sell
-5,400
Closed -$415K 1686
2022
Q4
$415K Buy
+5,400
New +$410K 0.02% 800

Other funds holding CAH

Point72 Middle East FZE's CAH Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Cardinal Health (CAH) in Q1 2024, closing a stake of 1,201 shares — an estimated $121K sold.

Point72 Middle East FZE first reported a position in CAH in Q4 2022 and held it in 4 quarters. The position peaked at $10.3M in Q3 2023. 1,058 funds tracked by Wall St. Rank hold CAH as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Cardinal Health position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 1,201 Cardinal Health shares in Q1 2024, an estimated $121K.
  • Point72 Middle East FZE first reported a position in Cardinal Health in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's Cardinal Health position peaked at $10.3M in Q3 2023.
  • 1,058 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.